A carregar...
Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer
BACKGROUND: To evaluate the efficacy and safety of Icotinib – an orally administered, highly potent selective inhibitor of epidermal growth factor receptor (EGFR) and its active mutations, in the treatment of patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 101 patients...
Na minha lista:
| Publicado no: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704301/ https://ncbi.nlm.nih.gov/pubmed/26767007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12085 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|